Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	145.97	161.44	79.93	143.24	47.7	74.85
Short-Term Investments	169.48	196.73	183.51	139.88	118.28	-
Cash & Short-Term Investments	315.45	358.16	263.44	283.11	165.98	74.85
Cash Growth	40.01%	35.96%	-6.95%	70.57%	121.74%	280.94%
Receivables	-	-	-	-	-	12.72
Prepaid Expenses	3.51	3.95	3.99	2.07	0.95	1.16
Other Current Assets	-	-	-	-	-	2.14
Total Current Assets	318.95	362.11	267.43	285.19	166.93	90.87
Property, Plant & Equipment	1.11	1.47	1.03	1.8	1.05	1.18
Other Long-Term Assets	0.36	0.35	0.06	0.04	0.09	0.25
Total Assets	320.42	363.93	268.52	287.03	168.07	92.29
Accounts Payable	2.85	2.15	2.52	1.65	2.13	0.94
Accrued Expenses	9.16	12.62	8.55	5.98	4.34	8.01
Short-Term Debt	-	-	-	-	-	12.88
Current Portion of Leases	0.44	0.43	0.6	0.66	-	-
Other Current Liabilities	0.46	0.46	0.28	0.19	0.36	1
Total Current Liabilities	12.91	15.65	11.94	8.47	6.82	22.82
Long-Term Leases	0.69	0.92	-	0.54	-	-
Other Long-Term Liabilities	1.58	1.49	1.21	1.07	0.95	0.88
Total Liabilities	15.19	18.06	13.15	10.08	7.77	23.7
Common Stock	0.01	0.01	0.01	0.01	0	-
Additional Paid-In Capital	774.72	767.62	588.01	520.18	342.71	14.6
Retained Earnings	-469.48	-421.48	-332.63	-242.42	-182.07	-131.92
Comprehensive Income & Other	-0.02	-0.28	-0.02	-0.82	-0.34	-0.12
Total Common Equity	305.23	345.87	255.37	276.94	160.3	-117.44
Shareholders' Equity	305.23	345.87	255.37	276.94	160.3	68.59
Total Liabilities & Equity	320.42	363.93	268.52	287.03	168.07	92.29
Total Debt	1.13	1.35	0.6	1.21	-	12.88
Net Cash (Debt)	314.31	356.82	262.84	281.91	165.98	61.97
Net Cash Growth	39.66%	35.76%	-6.77%	69.84%	167.82%	215.39%
Net Cash Per Share	3.57	4.49	3.69	7.82	7.31	217.33
Filing Date Shares Outstanding	87.51	87.3	64.65	56.67	25.27	25.13
Total Common Shares Outstanding	87.47	87.13	64.58	53.72	25.27	0.34
Working Capital	306.04	346.46	255.49	276.72	160.11	68.05
Book Value Per Share	3.49	3.97	3.95	5.16	6.34	-347.97
Tangible Book Value	305.23	345.87	255.37	276.94	160.3	-117.44
Tangible Book Value Per Share	3.49	3.97	3.95	5.16	6.34	-347.97
Machinery	-	1.36	1.38	1.4	1.3	0.97
Leasehold Improvements	-	0.75	0.73	0.76	0.93	0.9

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q